Avanos Medical, Inc. (AVNS)

Market Cap	1.47B
Revenue (ttm)	795.90M
Net Income (ttm)	42.90M
Shares Out	46.50M
EPS (ttm)	0.90
PE Ratio	35.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195,347
Open	31.44
Previous Close	31.75
Day's Range	31.43 - 31.89
52-Week Range	19.32 - 35.91
Beta	0.88
Analysts	Sell
Price Target	28.90 (-8.52%)
Earnings Date	Feb 22, 2023

About AVNS

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Joseph Woody
• Employees: 4,555
• Stock Exchange: NYSE
• Ticker Symbol: AVNS

Analyst Forecast

According to 9 analysts, the average rating for AVNS stock is "Sell." The 12-month stock price forecast is $28.9, which is a decrease of -8.52% from the latest price.

Price Target

$28.9

(-8.52% downside)

Analyst Consensus: Sell